gunagratinib
3-[2-(3,5-dimethoxyphenyl)ethynyl]-5-(methylamino)-1-[(3S)-1-prop-2-enoylpyrrolidin-3-yl]pyrazole-4-carboxamide
Molecular Identity
gunagratinib
3-[2-(3,5-dimethoxyphenyl)ethynyl]-5-(methylamino)-1-[(3S)-1-prop-2-enoylpyrrolidin-3-yl]pyrazole-4-carboxamide
PubChem CID: 138734912
2D Structure
Properties
C22H25N5O4
Molecular Formula
423.50
Molecular Weight
g/mol
423.1907
Exact Mass
Da
2.2
XLogP
Drug-like (Lipinski: < 5)
112
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
6
H-Bond Acceptors
735
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
gunagratinib2211082-53-8Gunagratinib [INN]9D589FD91AICP192ICP-192(S)-1-(1-Acryloylpyrrolidin-3-yl)-3-((3,5-dimethoxyphenyl)ethynyl)-5-(methylamino)-1H-pyrazole-4-carboxamide1H-Pyrazole-4-carboxamide, 3-(2-(3,5-dimethoxyphenyl)ethynyl)-5-(methylamino)-1-((3S)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl)-3-[2-(3,5-dimethoxyphenyl)ethynyl]-5-(methylamino)-1-[(3S)-1-prop-2-enoylpyrrolidin-3-yl]pyrazole-4-carboxamide3-(2-(3,5-dimethoxyphenyl)ethynyl)-5-(methylamino)-1-((3S)-1-prop-2-enoylpyrrolidin-3-yl)pyrazole-4-carboxamideRefChem:144787Pan-FGFR Inhibitor ICP-192ICP 192UNII-9D589FD91AGunagratinib [WHO-DD]
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to gunagratinib
Loading drug network...